Kaye Mark insider trades
Kaye Mark has filed 27 Form 4s with the SEC that we hold, for Moodys Corp /DE/ (MCO) (EVP & Chief Financial Officer), Elevance Health, Inc. (ELV) (EVP & CFO) and CONMED Corp (CNMD) (Director). Across all of them we count 0 purchases worth $0 and 29 sales worth $15.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 13 sales ($4.7M). The largest single trade was a sale of 4,588 shares of Elevance Health, Inc. worth $1.9M, dated 2025-04-24. Of 13 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-02 and the latest 2026-10-23.
Moodys Corp /DE/ (MCO)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-07-01 | S, sale reported on Form 4 | 43 | $15.6K | 2021-07-02 | SEC |
| 2021-08-16 | S, sale reported on Form 4 | 1,734 | $658.4K | 2021-08-17 | SEC |
| 2021-08-16 | S, sale reported on Form 4 | 1,043 | $396.0K | 2021-08-17 | SEC |
| 2021-08-16 | S, sale reported on Form 4 | 356 | $135.2K | 2021-08-17 | SEC |
| 2021-11-18 | S, sale reported on Form 4 | 316 | $125.9K | 2021-11-19 | SEC |
| 2022-03-02 | S, sale reported on Form 4 | 3,702 | $1.2M | 2022-03-03 | SEC |
| 2022-08-15 | S, sale reported on Form 4 | 1,374 | $442.8K | 2022-08-16 | SEC |
| 2022-08-15 | S, sale reported on Form 4 | 1,740 | $560.7K | 2022-08-16 | SEC |
| 2023-05-19 | S, sale reported on Form 4 | 975 | $310.0K | 2023-05-22 | SEC |
| 2023-08-07 | S, sale reported on Form 4 | 1,741 | $594.1K | 2023-08-08 | SEC |
| 2023-08-07 | S, sale reported on Form 4 | 3,470 | $1.2M | 2023-08-08 | SEC |
| 2023-08-07 | S, sale reported on Form 4 | 3,857 | $1.3M | 2023-08-08 | SEC |
| 2023-08-07 | S, sale reported on Form 4 | 1,544 | $526.3K | 2023-08-08 | SEC |
| 2023-08-07 | S, sale reported on Form 4 | 3,832 | $1.3M | 2023-08-08 | SEC |
| 2023-08-07 | S, sale reported on Form 4 | 714 | $243.5K | 2023-08-08 | SEC |
Elevance Health, Inc. (ELV)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2025-04-24 | S, sale reported on Form 4 | 4,588 | $1.9M | 2025-04-25 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 400 | $173.6K | 2026-10-23 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 321 | $139.7K | 2026-10-23 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 1,660 | $724.1K | 2026-10-23 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 560 | $244.8K | 2026-10-23 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 240 | $105.2K | 2026-10-23 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 1,160 | $509.5K | 2026-10-23 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 1,720 | $757.6K | 2026-10-23 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 2,343 | $1.0M | 2026-10-23 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 480 | $212.5K | 2026-10-23 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 440 | $195.3K | 2026-10-23 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 160 | $71.2K | 2026-10-23 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 827 | $368.9K | 2026-10-23 | SEC |
| 2026-10-22 | S, sale reported on Form 4 | 273 | $122.1K | 2026-10-23 | SEC |
CONMED Corp (CNMD)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1748691) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
